Literature DB >> 3954725

Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum.

G L Francis, L C Read, F J Ballard, C J Bagley, F M Upton, P M Gravestock, J C Wallace.   

Abstract

Growth-promoting activity in bovine colostrum has been detected as the capacity to stimulate protein synthesis in L6 myoblasts. By using this assay as a measure of bioactivity, a growth factor has been purified to near homogeneity from centrifuged colostrum by a series of steps including acid extraction, chromatography on sulphopropyl-Sephadex, followed by adsorption to, and elution from, C18 columns using acetonitrile and propan-1-ol gradients. The purified growth factor has a low solubility at neutral and alkaline pH and has an Mr of 7800 by gel-permeation chromatography. Sequence analysis of the first 30 amino acids from the N-terminus indicated complete identity in this region with human insulin-like growth factor-1. Accordingly we conclude that the purified growth factor is bovine insulin-like growth factor-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954725      PMCID: PMC1153005          DOI: 10.1042/bj2330207

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Tertiary structures, receptor binding, and antigenicity of insulinlike growth factors.

Authors:  T L Blundell; S Bedarkar; R E Humbel
Journal:  Fed Proc       Date:  1983-06

3.  High-sensitivity sequencing with a gas-phase sequenator.

Authors:  M W Hunkapiller; R M Hewick; W J Dreyer; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Removal of fatty acids from serum albumin by charcoal treatment.

Authors:  R F Chen
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

5.  Partial purification and characterization of a growth factor present in goat's colostrum. Similarities with platelet-derived growth factor.

Authors:  K D Brown; D M Blakeley
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

6.  Human and bovine milk contain different sets of growth factors.

Authors:  Y W Shing; M Klagsbrun
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

7.  Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1.

Authors:  L C Read; F J Ballard; G L Francis; R C Baxter; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

8.  Changes in the growth-promoting activity of human milk during lactation.

Authors:  L C Read; F M Upton; G L Francis; J C Wallace; G W Dahlenberg; F J Ballard
Journal:  Pediatr Res       Date:  1984-02       Impact factor: 3.756

9.  Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.

Authors:  F J Ballard; L C Read; G L Francis; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

10.  Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk.

Authors:  R C Baxter; Z Zaltsman; J R Turtle
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

View more
  15 in total

1.  Veterinary nutraceutical medicine.

Authors:  C Taillon; A Andreasen
Journal:  Can Vet J       Date:  2000-03       Impact factor: 1.008

2.  Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action. Evidence derived from the use of a truncated IGF-I analogue.

Authors:  E Y Adashi; C E Resnick; E Ricciarelli; A Hurwitz; E Kokia; C Tedeschi; L Botero; E R Hernandez; R G Rosenfeld; C Carlsson-Skwirut
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.

Authors:  M Ross; G L Francis; L Szabo; J C Wallace; F J Ballard
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

4.  Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively.

Authors:  F J Ballard; M Ross; F M Upton; G L Francis
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

5.  A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide.

Authors:  C J Bagley; B L May; L Szabo; P J McNamara; M Ross; G L Francis; F J Ballard; J C Wallace
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

Review 6.  Growth factors, apoptosis, and survival of mammary epithelial cells.

Authors:  E C Rosfjord; R B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

7.  Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.

Authors:  G L Francis; S E Aplin; S J Milner; K A McNeil; F J Ballard; J C Wallace
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

8.  An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I.

Authors:  G Forsberg; B Baastrup; H Rondahl; E Holmgren; G Pohl; M Hartmanis; M Lake
Journal:  J Protein Chem       Date:  1992-04

9.  Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1.

Authors:  L C Read; F J Ballard; G L Francis; R C Baxter; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

10.  Regulation of protein metabolism and DNA synthesis by fibroblast growth factor in BHK-21 cells.

Authors:  M Ross; F J Ballard
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.